{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04913285",
            "orgStudyIdInfo": {
                "id": "KN-8701"
            },
            "secondaryIdInfos": [
                {
                    "id": "KIN 2787CI101",
                    "type": "OTHER",
                    "domain": "Pierre Fabre Medicament"
                }
            ],
            "organization": {
                "fullName": "Pierre Fabre Medicament",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors",
            "officialTitle": "A Phase 1/1b Open-label, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of KIN-2787 in Participants With BRAF and/or NRAS Mutation-positive Solid Tumors.",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "a-study-to-evaluate-kin-in-participants-with-braf-and-or-nras-mutation-positive-solid-tumors"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-10",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-08-04",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12-07",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-05-18",
            "studyFirstSubmitQcDate": "2021-05-28",
            "studyFirstPostDateStruct": {
                "date": "2021-06-04",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-11",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-12",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Pierre Fabre Medicament",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of KIN-2787 in adults with BRAF/NRAS-mutated advanced or metastatic solid tumors.",
            "detailedDescription": "This is a two-part, open-label, multi-center, dose escalation and dose expansion study in participants with BRAF mutation-positive and/or NRAS mutation-positive tumors designed to evaluate the safety, tolerability, and pharmacokinetics (PK) of KIN-2787, a RAF small molecule kinase inhibitor, to determine a recommended Phase 2 dose (RP2D) of KIN-2787, and to assess the objective response to KIN-2787 therapy alone and in combination with binimetinib, a mitogen-activated protein kinase (MEK) inhibitor.\n\nThe dose expansion phase (Part B) will assess the safety and efficacy of KIN-2787 at the recommended dose and schedule in patients with cancers that contain BRAF Class I, II or III mutations, including lung cancer, melanoma, and other selected solid tumors."
        },
        "conditionsModule": {
            "conditions": [
                "Solid Tumor, Adult",
                "Non-small Cell Lung Cancer",
                "Melanoma"
            ],
            "keywords": [
                "BRAF inhibitor",
                "BRAF",
                "pan-RAF",
                "pan-RAF inhibitor",
                "RAF1",
                "ARAF",
                "BRAF alteration",
                "BRAF Class II",
                "BRAF Class III",
                "V600",
                "tumor growth inhibitor (TGI)",
                "melanoma",
                "NSCLC",
                "solid tumor",
                "targeted therapy",
                "BRAF Class I",
                "NRAS",
                "Metastatic",
                "Unresectable",
                "CRC",
                "ATC",
                "Colon",
                "Thyroid",
                "Advanced",
                "Exarafenib",
                "binimetinib"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 400,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Dose Escalation Monotherapy (Part A1)",
                    "type": "EXPERIMENTAL",
                    "description": "Dose escalation of KIN-2787",
                    "interventionNames": [
                        "Drug: KIN-2787"
                    ]
                },
                {
                    "label": "Dose Escalation Combination therapy (Part A2)",
                    "type": "EXPERIMENTAL",
                    "description": "Dose escalation of KIN-2787 and binimetinib",
                    "interventionNames": [
                        "Drug: KIN-2787 and binimetinib"
                    ]
                },
                {
                    "label": "Dose Expansion Monotherapy (Part B1)",
                    "type": "EXPERIMENTAL",
                    "description": "Dose expansion evaluating the recommended phase 2 dose (RP2D) of KIN-2787",
                    "interventionNames": [
                        "Drug: KIN-2787"
                    ]
                },
                {
                    "label": "Dose Escalation Combination therapy (Part B2)",
                    "type": "EXPERIMENTAL",
                    "description": "Dose expansion evaluating the recommended phase 2 dose (RP2D) of KIN-2787 and binimetinib",
                    "interventionNames": [
                        "Drug: KIN-2787 and binimetinib"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "KIN-2787",
                    "description": "KIN-2787 will be administered orally twice daily in 28-day cycles",
                    "armGroupLabels": [
                        "Dose Escalation Monotherapy (Part A1)",
                        "Dose Expansion Monotherapy (Part B1)"
                    ],
                    "otherNames": [
                        "exarafenib"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "KIN-2787 and binimetinib",
                    "description": "KIN-2787 and binimetinib will be administered orally twice daily in 28-day cycles",
                    "armGroupLabels": [
                        "Dose Escalation Combination therapy (Part A2)",
                        "Dose Escalation Combination therapy (Part B2)"
                    ],
                    "otherNames": [
                        "exarafenib and binimetinib"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Part A1 Dose escalation monotherapy:",
                    "description": "To determine the safety and tolerability of oral administration of KIN-2787 including dose-limiting toxicities (DLTs), and to identify the maximum tolerated dose (MTD) and/or the appropriate dose for further clinical investigation in Part B Dose Expansion.",
                    "timeFrame": "Initiation of study drug through 28 days after last dose (up to approximately 18 months)"
                },
                {
                    "measure": "Part A2 Dose Escalation: KIN-2787 + Binimetinib Combination",
                    "description": "To determine the safety and tolerability of oral administration of KIN-2787 + binimetinib including DLTs, and to identify the MTD and/or the appropriate dose for further clinical investigation.",
                    "timeFrame": "Initiation of study drug through 28 days after last dose (up to approximately 18 months)"
                },
                {
                    "measure": "In Part B (Dose Expansion) - objective response rate (ORR) using RECIST v1.1.",
                    "description": "To assess preliminary evidence of the anti-cancer activity of KIN-2787 and for (B2) KIN-2787 + binimetinib",
                    "timeFrame": "Initiation of study drug until disease progression (up to approximately 36 months)"
                },
                {
                    "measure": "In Part B (Dose Expansion) - disease control rate (DCR).",
                    "timeFrame": "Initiation of study drug until disease progression (up to approximately 36 months)"
                },
                {
                    "measure": "In Part B (Dose Expansion) - duration of overall response (DOR).",
                    "description": "Measure of clinical benefit, defined as the time from initial tumor response to documented tumor progression",
                    "timeFrame": "Initiation of study drug until disease progression (up to approximately 36 months)"
                },
                {
                    "measure": "In Part B (Dose Expansion) - duration of stable disease.",
                    "timeFrame": "Initiation of study drug until disease progression (up to approximately 36 months)"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Part A1 Dose Escalation: Characterization of PK properties and effect of food on PK of KIN-2787 including, but not limited to tmax.",
                    "timeFrame": "Initiation of study drug through Cycle 5, where each cycle is 28 days (up to approximately 4 months)"
                },
                {
                    "measure": "Part A1 Dose Escalation: Characterization of PK properties and effect of food on PK of KIN-2787 including, but not limited to AUC.",
                    "timeFrame": "Initiation of study drug through Cycle 5, where each cycle is 28 days (up to approximately 4 months)"
                },
                {
                    "measure": "Part A1 Dose Escalation: Characterization of PK properties and effect of food on PK of KIN-2787 including, but not limited to Cmax.",
                    "timeFrame": "Initiation of study drug through Cycle 5, where each cycle is 28 days (up to approximately 4 months)"
                },
                {
                    "measure": "Part A2 Dose Escalation: characterization of PK properties of KIN-2787 and binimetinib in combination including, but not limited to Cmax.",
                    "timeFrame": "Initiation of study drug through Cycle 5, where each cycle is 28 days (up to approximately 4 months)"
                },
                {
                    "measure": "Part A2 Dose Escalation: characterization of PK properties of KIN-2787 and binimetinib in combination including, but not limited to AUC.",
                    "timeFrame": "Initiation of study drug through Cycle 5, where each cycle is 28 days (up to approximately 4 months)"
                },
                {
                    "measure": "Part A2 Dose Escalation: characterization of PK properties of KIN-2787 and binimetinib in combination including, but not limited to tmax.",
                    "timeFrame": "Initiation of study drug through Cycle 5, where each cycle is 28 days (up to approximately 4 months)"
                },
                {
                    "measure": "Part B Dose Expansion: characterization of PK properties of KIN-2787, and for (B2) KIN-2787 + binimetinib including, but not limited to AUC.",
                    "timeFrame": "Initiation of study drug through Cycle 5, where each cycle is 28 days (up to approximately 4 months)"
                },
                {
                    "measure": "Part B Dose Expansion: characterization of PK properties of KIN-2787, and for (B2) KIN-2787 + binimetinib including, but not limited to Cmax.",
                    "timeFrame": "Initiation of study drug through Cycle 5, where each cycle is 28 days (up to approximately 4 months)"
                },
                {
                    "measure": "Part B Dose Expansion: characterization of PK properties of KIN-2787, and for (B2) KIN-2787 + binimetinib including, but not limited to tmax.",
                    "timeFrame": "Initiation of study drug through Cycle 5, where each cycle is 28 days (up to approximately 4 months)"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Provide written informed consent prior to initiation of any study-specific procedures.\n* Metastatic or advanced stage solid tumor\n* Known BRAF Class I, Class II, or Class III alteration or melanoma with an NRAS mutation as confirmed by previous genomic analysis of tumor tissue or ctDNA.\n* Measurable (Part A and B) or evaluable (Part A only) disease by RECIST v1.1.\n* ECOG performance status 0-1\n* Adequate organ function, as measured by laboratory values (criteria listed in protocol).\n* Able to swallow, retain, and absorb oral medications.\n\nExclusion Criteria:\n\n* Known participants who have received local therapy with either surgery and/or radiation therapy (participants with asymptomatic untreated brain metastasis may be eligible if met with certain criteria)\n* In Part B Dose Expansion, previous treatment with any approved or in-development small molecule BRAF-, MEK-, or MAPK-directed inhibitor therapy.\n* GI tract disease causing an inability to take oral medication, malabsorption syndrome, requirement for intravenous alimentation, or uncontrolled inflammatory GI disease.\n* Active, uncontrolled bacterial, fungal, or viral infection.\n* Participant with a positive test result for SARS-CoV2 infection, is known to have asymptomatic infection or is suspected of having SARS-CoV2, is excluded\n* Women who are lactating or breastfeeding, or pregnant.\n* Participants with any other active treated malignancy within 3 years prior to enrollment\n\nComplete inclusion and exclusion criteria are listed in the clinical study protocol.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Claire Fabre, MD",
                    "role": "CONTACT",
                    "phone": "+33534506059",
                    "email": "claire.fabre@pierre-fabre.com"
                },
                {
                    "name": "Moutaffian Helene, PhD",
                    "role": "CONTACT",
                    "phone": "+33772344986",
                    "email": "helene.moutaffian@pierre-fabre.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "CLaire FABRE, MD",
                    "affiliation": "Pierre Fabre Laboratories",
                    "role": "STUDY_CHAIR"
                }
            ],
            "locations": [
                {
                    "facility": "City of Hope",
                    "status": "COMPLETED",
                    "city": "Duarte",
                    "state": "California",
                    "zip": "91010",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.13945,
                        "lon": -117.97729
                    }
                },
                {
                    "facility": "Providence",
                    "status": "COMPLETED",
                    "city": "Fullerton",
                    "state": "California",
                    "zip": "92835",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.87029,
                        "lon": -117.92534
                    }
                },
                {
                    "facility": "UCSD Moores Cancer Center",
                    "status": "RECRUITING",
                    "city": "La Jolla",
                    "state": "California",
                    "zip": "92093",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Julia Appelt, CCRC",
                            "role": "CONTACT",
                            "phone": "858-822-0201",
                            "email": "jappelt@health.ucsd.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.84727,
                        "lon": -117.2742
                    }
                },
                {
                    "facility": "University of Southern California",
                    "status": "COMPLETED",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90033",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "UCLA",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90095",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jessica Crocker",
                            "role": "CONTACT",
                            "email": "JCrocker@mednet.ucla.edu"
                        },
                        {
                            "name": "Bartosz Chmielowski, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "UC Davis",
                    "status": "COMPLETED",
                    "city": "Sacramento",
                    "state": "California",
                    "zip": "95817",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.58157,
                        "lon": -121.4944
                    }
                },
                {
                    "facility": "Providence Medical Foundation (St. Joseph's)",
                    "status": "COMPLETED",
                    "city": "Santa Rosa",
                    "state": "California",
                    "zip": "95403",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.44047,
                        "lon": -122.71443
                    }
                },
                {
                    "facility": "Stanford Cancer Center",
                    "status": "RECRUITING",
                    "city": "Stanford",
                    "state": "California",
                    "zip": "94305",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Debjani Ghoshal",
                            "role": "CONTACT",
                            "email": "dghoshal@stanford.edu"
                        },
                        {
                            "name": "Chris Chen, MD",
                            "role": "CONTACT",
                            "email": "ctjchen@stanford.edu"
                        },
                        {
                            "name": "Chris Chen, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.42411,
                        "lon": -122.16608
                    }
                },
                {
                    "facility": "Orlando Health Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Orlando",
                    "state": "Florida",
                    "zip": "32806",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sajeve Thomas, MD",
                            "role": "CONTACT",
                            "email": "Sajeve.Thomas@orlandohealth.com"
                        },
                        {
                            "name": "Sajeve Thomas, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 28.53834,
                        "lon": -81.37924
                    }
                },
                {
                    "facility": "Sarah Cannon Research Institute - Lake Nona",
                    "status": "RECRUITING",
                    "city": "Orlando",
                    "state": "Florida",
                    "zip": "32827",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "email": "asksarah@sarahcannon.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 28.53834,
                        "lon": -81.37924
                    }
                },
                {
                    "facility": "Moffitt Cancer Ceter",
                    "status": "RECRUITING",
                    "city": "Tampa",
                    "state": "Florida",
                    "zip": "33612",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Cody Likens",
                            "role": "CONTACT"
                        },
                        {
                            "role": "CONTACT",
                            "email": "cody.likens@moffitt.org"
                        },
                        {
                            "name": "Hao Xie, MD, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 27.94752,
                        "lon": -82.45843
                    }
                },
                {
                    "facility": "Decatur Memorial Hospital",
                    "status": "COMPLETED",
                    "city": "Decatur",
                    "state": "Illinois",
                    "zip": "62526",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.84031,
                        "lon": -88.9548
                    }
                },
                {
                    "facility": "Center for Cancer and Blood Disorders",
                    "status": "COMPLETED",
                    "city": "Bethesda",
                    "state": "Maryland",
                    "zip": "20817",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.98067,
                        "lon": -77.10026
                    }
                },
                {
                    "facility": "NYU Langone",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10016",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "CT.gov@nyulangone.org",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Janice Mehnert, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Memorial Sloan Kettering Cancer Center",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10065",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Michael Offin",
                            "role": "CONTACT",
                            "email": "offinm@mskcc.org"
                        },
                        {
                            "name": "Michael Offin, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Cleveland Clinic",
                    "status": "RECRUITING",
                    "city": "Cleveland",
                    "state": "Ohio",
                    "zip": "44195",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "TaussigResearch@ccf.org",
                            "role": "CONTACT",
                            "phone": "216-444-7923"
                        },
                        {
                            "name": "Dale Shepard, MD, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.4995,
                        "lon": -81.69541
                    }
                },
                {
                    "facility": "Fox Chase Cancer Center",
                    "status": "COMPLETED",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19111",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "Thomas Jefferson",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19114",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "Sarah Cannon Research Institute",
                    "status": "RECRUITING",
                    "city": "Nashville",
                    "state": "Tennessee",
                    "zip": "37203",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "844-482-4812"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.16589,
                        "lon": -86.78444
                    }
                },
                {
                    "facility": "Virginia Cancer Specialists",
                    "status": "RECRUITING",
                    "city": "Fairfax",
                    "state": "Virginia",
                    "zip": "22031",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Carrie Friedman, RN, BSN, OCN",
                            "role": "CONTACT",
                            "phone": "703-636-1473",
                            "email": "vcsclinicaltrials@usoncology.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.84622,
                        "lon": -77.30637
                    }
                },
                {
                    "facility": "Northwest Medical Specialties",
                    "status": "COMPLETED",
                    "city": "Tacoma",
                    "state": "Washington",
                    "zip": "98405",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 47.25288,
                        "lon": -122.44429
                    }
                },
                {
                    "facility": "Melanoma Institute Australia",
                    "status": "RECRUITING",
                    "city": "Wollstonecraft",
                    "state": "New South Wales",
                    "zip": "2065",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -33.8328,
                        "lon": 151.18981
                    }
                },
                {
                    "facility": "Linear Clinical Research",
                    "status": "RECRUITING",
                    "city": "Perth",
                    "state": "Western Australia",
                    "zip": "6009",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Michael Millward, Professor",
                            "role": "CONTACT",
                            "phone": "(08) 6382 5100",
                            "email": "cancertrialsstartup@linear.org.au"
                        }
                    ],
                    "geoPoint": {
                        "lat": -31.95224,
                        "lon": 115.8614
                    }
                },
                {
                    "facility": "Union Hospital of Tongji Medical College of HUST",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Wuhan",
                    "state": "Hubei",
                    "zip": "430023",
                    "country": "China",
                    "geoPoint": {
                        "lat": 30.58333,
                        "lon": 114.26667
                    }
                },
                {
                    "facility": "Linyi Cancer Hospital",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Linyi",
                    "state": "Shandong",
                    "zip": "276001",
                    "country": "China",
                    "geoPoint": {
                        "lat": 35.06306,
                        "lon": 118.34278
                    }
                },
                {
                    "facility": "Beijing University Cancer Hospital",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Beijing",
                    "zip": "100142",
                    "country": "China",
                    "geoPoint": {
                        "lat": 39.9075,
                        "lon": 116.39723
                    }
                },
                {
                    "facility": "The Shanghai Pulmonary Hospital",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Shanghai",
                    "zip": "200433",
                    "country": "China",
                    "geoPoint": {
                        "lat": 31.22222,
                        "lon": 121.45806
                    }
                },
                {
                    "facility": "Institut Bergonie",
                    "status": "RECRUITING",
                    "city": "Bordeaux",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Antonie Italiano",
                            "role": "CONTACT",
                            "phone": "+33 5 47 30 60 88",
                            "email": "a.italiano@bordeaux.unicancer.fr"
                        },
                        {
                            "name": "Antonie Italiano, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.84044,
                        "lon": -0.5805
                    }
                },
                {
                    "facility": "Centre Leon Berard",
                    "status": "RECRUITING",
                    "city": "Lyon",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Philippe Cassier",
                            "role": "CONTACT",
                            "phone": "+33 4 26 55 68 33",
                            "email": "philippe.cassier@lyon.unicancer.fr"
                        },
                        {
                            "name": "Philippe Cassier, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.74848,
                        "lon": 4.84669
                    }
                },
                {
                    "facility": "APHM-CHU La Timone",
                    "status": "RECRUITING",
                    "city": "Marseille",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Caroline Gaudy",
                            "role": "CONTACT",
                            "phone": "+33 (0) 4 91 38 75 94",
                            "email": "mailto:caroline.gaudy@ap-hm.fr"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.29551,
                        "lon": 5.38958
                    }
                },
                {
                    "facility": "CHU Nantes-Hotel Dieu",
                    "status": "RECRUITING",
                    "city": "Nantes",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Stephanie Bordenave",
                            "role": "CONTACT",
                            "phone": "+33 2 40 16 59 30",
                            "email": "stephanie.bordenave@chu-nantes.fr"
                        },
                        {
                            "name": "Stephanie Bordenave, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.21725,
                        "lon": -1.55336
                    }
                },
                {
                    "facility": "Gustave Roussy",
                    "status": "RECRUITING",
                    "city": "Villejuif",
                    "zip": "94805",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "David Planchard, MD",
                            "role": "CONTACT",
                            "phone": "+ 33 (0)1 42 11 45 64",
                            "email": "David.PLANCHARD@gustaveroussy.fr"
                        },
                        {
                            "name": "David Planchard, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 48.7939,
                        "lon": 2.35992
                    }
                },
                {
                    "facility": "Chungbuk National University Hospital",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Cheongju-si",
                    "zip": "28644",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 36.63722,
                        "lon": 127.48972
                    }
                },
                {
                    "facility": "Seoul National University Hospital",
                    "status": "COMPLETED",
                    "city": "Seoul",
                    "zip": "03080",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Samsung Medical Center",
                    "status": "COMPLETED",
                    "city": "Seoul",
                    "zip": "06351",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Netherlands Cancer Institute",
                    "status": "COMPLETED",
                    "city": "Amsterdam",
                    "country": "Netherlands",
                    "geoPoint": {
                        "lat": 52.37403,
                        "lon": 4.88969
                    }
                },
                {
                    "facility": "Vall d'Hebron Institute of Oncology (VHIO)",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "zip": "08035",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Eva Mu\u00f1oz",
                            "role": "CONTACT",
                            "phone": "+ 34 34 93 274 60 00",
                            "email": "emunoz@vhio.net"
                        },
                        {
                            "name": "Eva Mu\u00f1oz, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Hospital Quiron Dexeus",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Mar\u00eda Mar\u00eda Gonz\u00e1lez Cao, MD",
                            "role": "CONTACT",
                            "phone": "+34 93 546 01 35",
                            "email": "mgonzalezcao@oncorosell.com"
                        },
                        {
                            "name": "Mar\u00eda Mar\u00eda Gonz\u00e1lez Cao, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Hospital Universitario Insular de Gran Canaria",
                    "status": "RECRUITING",
                    "city": "Las Palmas De Gran Canaria",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Delvys Rodr\u00edguez",
                            "role": "CONTACT",
                            "phone": "+34 928 44 17 38",
                            "email": "drodabr@gobiernodecanarias.org"
                        },
                        {
                            "name": "Delvys Rodr\u00edguez, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 28.09973,
                        "lon": -15.41343
                    }
                },
                {
                    "facility": "Hospital General Gregorio Mara\u00f1\u00f3n",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "zip": "29009",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Antonio Calles Blanco, MD",
                            "role": "CONTACT",
                            "phone": "+ 34 914 26 95 16",
                            "email": "antonio.calles@live.com"
                        },
                        {
                            "role": "CONTACT",
                            "phone": "+ 34 915 86 81 15"
                        },
                        {
                            "name": "Antonio Calles Blanco, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "INCLIVA (Hospital Clinico de Valencia)",
                    "status": "RECRUITING",
                    "city": "Valencia",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Valentina Gambardella, MD",
                            "role": "CONTACT",
                            "phone": "+34 961 97 35 31/+34 961 97 4",
                            "email": "valen.gambardella@gmail.com"
                        },
                        {
                            "name": "Valentina Gambardella, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.46975,
                        "lon": -0.37739
                    }
                },
                {
                    "facility": "Taipei Veterans General Hospital",
                    "status": "COMPLETED",
                    "city": "Taipei",
                    "zip": "11217",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 25.04776,
                        "lon": 121.53185
                    }
                },
                {
                    "facility": "National Taiwan University Hospital",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Taipei",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 25.04776,
                        "lon": 121.53185
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008545",
                    "term": "Melanoma"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000018358",
                    "term": "Neuroendocrine Tumors"
                },
                {
                    "id": "D000017599",
                    "term": "Neuroectodermal Tumors"
                },
                {
                    "id": "D000009373",
                    "term": "Neoplasms, Germ Cell and Embryonal"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009380",
                    "term": "Neoplasms, Nerve Tissue"
                },
                {
                    "id": "D000018326",
                    "term": "Nevi and Melanomas"
                },
                {
                    "id": "D000012878",
                    "term": "Skin Neoplasms"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5546",
                    "name": "Carcinoma, Non-Small-Cell Lung",
                    "relevance": "LOW"
                },
                {
                    "id": "M11172",
                    "name": "Lung Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M16718",
                    "name": "Thyroid Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11528",
                    "name": "Melanoma",
                    "asFound": "Melanoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M20495",
                    "name": "Neuroendocrine Tumors",
                    "relevance": "LOW"
                },
                {
                    "id": "M19845",
                    "name": "Neuroectodermal Tumors",
                    "relevance": "LOW"
                },
                {
                    "id": "M20388",
                    "name": "Neuroectodermal Tumors, Primitive",
                    "relevance": "LOW"
                },
                {
                    "id": "M12318",
                    "name": "Neoplasms, Germ Cell and Embryonal",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M12325",
                    "name": "Neoplasms, Nerve Tissue",
                    "relevance": "LOW"
                },
                {
                    "id": "M12448",
                    "name": "Nevus, Pigmented",
                    "relevance": "LOW"
                },
                {
                    "id": "M12446",
                    "name": "Nevus",
                    "relevance": "LOW"
                },
                {
                    "id": "M20470",
                    "name": "Nevi and Melanomas",
                    "relevance": "LOW"
                },
                {
                    "id": "M15681",
                    "name": "Skin Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T4091",
                    "name": "Neuroendocrine Tumor",
                    "relevance": "LOW"
                },
                {
                    "id": "T4092",
                    "name": "Neuroepithelioma",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M9231",
                    "name": "Growth Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "T120",
                    "name": "Cola",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "HB",
                    "name": "Herbal and Botanical"
                }
            ]
        }
    },
    "hasResults": false
}